1. Home
  2. MRSN vs SWAG Comparison

MRSN vs SWAG Comparison

Compare MRSN & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SWAG
  • Stock Information
  • Founded
  • MRSN 2001
  • SWAG 1994
  • Country
  • MRSN United States
  • SWAG United States
  • Employees
  • MRSN N/A
  • SWAG N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SWAG Advertising
  • Sector
  • MRSN Health Care
  • SWAG Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • SWAG Nasdaq
  • Market Cap
  • MRSN 37.0M
  • SWAG 30.4M
  • IPO Year
  • MRSN 2017
  • SWAG 2021
  • Fundamental
  • Price
  • MRSN $7.15
  • SWAG $1.89
  • Analyst Decision
  • MRSN Strong Buy
  • SWAG
  • Analyst Count
  • MRSN 3
  • SWAG 0
  • Target Price
  • MRSN $33.00
  • SWAG N/A
  • AVG Volume (30 Days)
  • MRSN 62.6K
  • SWAG 128.0K
  • Earning Date
  • MRSN 11-12-2025
  • SWAG 11-06-2025
  • Dividend Yield
  • MRSN N/A
  • SWAG N/A
  • EPS Growth
  • MRSN N/A
  • SWAG N/A
  • EPS
  • MRSN N/A
  • SWAG N/A
  • Revenue
  • MRSN $34,769,000.00
  • SWAG $108,405,000.00
  • Revenue This Year
  • MRSN N/A
  • SWAG N/A
  • Revenue Next Year
  • MRSN N/A
  • SWAG N/A
  • P/E Ratio
  • MRSN N/A
  • SWAG N/A
  • Revenue Growth
  • MRSN 16.14
  • SWAG 38.74
  • 52 Week Low
  • MRSN $5.21
  • SWAG $0.73
  • 52 Week High
  • MRSN $70.75
  • SWAG $1.96
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 47.47
  • SWAG 62.49
  • Support Level
  • MRSN $7.04
  • SWAG $1.79
  • Resistance Level
  • MRSN $7.49
  • SWAG $1.96
  • Average True Range (ATR)
  • MRSN 0.44
  • SWAG 0.09
  • MACD
  • MRSN 0.00
  • SWAG 0.00
  • Stochastic Oscillator
  • MRSN 36.53
  • SWAG 79.35

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

Share on Social Networks: